Accord Challenges Roche's Patent Over Herceptin Reformulation
An expert witness told the High Court on Wednesday that pharma giant Roche's patent over a breast cancer drug is valid and novel, supporting the company's opposition to a patent challenge...To view the full article, register now.
Already a subscriber? Click here to view full article